Statistics
Publications
2
Citations
59
H-Index
2
Active since
2017
Affiliations
Harvard University(Current)
Robert Sherburne is an author at Harvard University specializing in clinical trials, inflammation biology, and chronic inflammation.
Publications per year
2017–2020
2
2
Icosapent Ethyl – A Successful Treatment for Symptomatic COVID-19 Infection
Amnon A. Berger, Robert Sherburne, Ivan Urits et al. · Cureus · 2020 · 15 citations · Full text
1–2 of 2